NIH #5R01HG000395-02
GENETIC MAP OF HUMAN CHROMOSOME 1
- Amount
- $323K
- Period
- 1991-04-01 → 1994-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Cancer Genomics and Diagnostics · Cancer Research
9 total · 0 active
NIH #5R01HG000395-02
Awarded at MASSACHUSETTS INSTITUTE OF TECHNOLOGY
NIH #1R01HG000395-01
Awarded at MASSACHUSETTS INSTITUTE OF TECHNOLOGY
NIH #5R01HG000395-03
Awarded at MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
medRxiv · 2026-02-23
EBioMedicine · 2025-12-16 · 4 citations
Molecular Cancer Therapeutics · 2025-10-22
Zeitschrift für Gastroenterologie · 2025-09-01
Evaluating lung cancer clinical characteristics and tumor subtypes using cell-free DNA fragmentomes.
Journal of Clinical Oncology · 2025-05-28 · 1 citations
Cancer Research · 2025-04-21
Abstract 3772: Leveraging the cfDNA fragmentome to predict immunotherapy response
Cancer Research · 2025-04-21 · 1 citations
Abstract 1961: Analysis of lung cancer clinical characteristics using cell-free DNA fragmentomes
Cancer Research · 2025-04-21
Abstract B025: Monitoring response to immunotherapy in lung cancer using cell-free DNA fragmentomes
Clinical Cancer Research · 2024-11-13 · 1 citations
2024-11-01
34 Monitoring response to immunotherapy in lung cancer using cell-free DNA fragmentomes
Regular and Young Investigator Award Abstracts · 2024-11-01
2024-11-01
2024-11-01
2024-11-01
2024-11-01
2024-11-01
2024-11-01
2024-11-01
2024-11-01
Cancer treatment monitoring using cell-free DNA fragmentomes
Nature Communications · 2024-10-21 · 38 citations